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In the last decade there has been growing realization that traumatic brain injury (TBI) can trigger 
a lifelong disease process1. In particular, there is increasing alarm around recognition of a form 
of neurodegenerative disease, chronic traumatic encephalopathy (CTE), in former athletes from 
an ever-expanding list of contact sports2. However, despite impressions from the popular media 
and certain sectors of the research community, TBI and its long-term consequences, including 
CTE, are far from exclusive to athletes.  
 
Since 2001, over 2 million United States service members have been deployed to conflicts in 
Iraq and Afghanistan, with over 313,000 sustaining at least one TBI, the vast majority as 
concussion or mild TBI3. Of particular concern among these injuries are those arising from 
exposure to blast shockwave, such as from improvised explosive devices4.  Indeed, blast 
associated TBI (bTBI) has often been referred to as a signature injury of modern military 
conflicts; with a combined US Veteran’s Administration and Department of Defense research 
spending on TBI estimated at over 2 billion dollars in the past decade5. Nevertheless, despite 
this significant research investment, understanding of bTBI is paralyzed by a singular lack of 
human neuropathology studies in those exposed to blast. As a consequence, there have been 
no means to evaluate the relevance of preclinical models, resulting in substantial confusion over 
what constitutes bTBI. Furthermore, for service members with blast exposure and TBI, it 
remains unclear whether their symptoms are a result of blast alone or potential accompanying 
blunt forces from head impact. 
 
In this edition Shively at al6 report their observations on the neuropathology of 8 former military 
personnel exposed to blast compared to small numbers of civilian controls with or without 
histories of TBI or opiate misuse. The authors report a distinctive astroglial pathology in all their 
chronic blast survival cases (greater than 6 months from injury) marked by dense astrogliosis at 
the boundary between cortical grey and underlying white matter, adjacent to the ventricles and 
subpially. Furthermore, they report reactive gliosis in a similar distribution in more acute blast 
survival cases (4 to 60 day survival after injury). In contrast, no similar astroglial pathology was 
observed in their limited series of controls, including blunt/impact TBI cases.  In addition to this 
glial pathology, the authors report axonal pathology in all three acute and 2 of 5 late blast cases, 
however, without formal characterization of pattern and distribution. 
 
Remarkably, this short series almost doubles the number of cases in the modern era describing 
the human neuropathology of blast TBI. Prior to this study, only 10 contemporary cases of bTBI 
had been described in the literature, half reporting a pathology reminiscent of CTE7,8, the 
remainder describing axonal pathology and no evidence of CTE9. Thus the picture of late 
pathology after bTBI remained unclear. However, while these previous reports fail to reach 
commonality in pathology described, they do share many unavoidable weaknesses in design, 
most notably in the considerable heterogeneity in survivals and in exposure to non-blast TBI 
among their limited number of cases.   
 
Inevitably, this latest contribution also suffers from heterogeneity in survival from injury (4 days 
to 9 years) and in histories of exposure to non-blast TBI (‘unknown’ in 6 cases)6, and whether 
the observations on specificity of this glial pathology to bTBI stand up to scrutiny in more 
comprehensive studies remains to be seen. Intriguingly, tau pathology reminiscent of CTE was 
only observed in 2 of this current series. However, as with previous neuropathological studies in 
bTBI, it cannot be determined if this CTE pathology represents a consequence of blast 
exposure alone, or is confounded by coincidental or previous non-blast injury.  In this regard, 
one bTBI case with CTE had a history of non-blast injury described as ‘unknown’, whilst the 
second had an extensive history including sports (wrestling, boxing) and non-sports (multiple 
motor vehicle accidents) TBI exposure.  At issue is the inability to rule out a previous TBI for 
almost any service member, where years of potential TBI exposure through military training, 
sports and accidents are more the rule than the exception.10   
 
Unquestionably this current study is commendable in drawing attention to the need for careful 
study of human tissue to further understanding of TBI. However, far from an answer to the 
question, ‘what is blast TBI’, the work instead exposes the remarkable absence of robust and 
informed human neuropathology studies in this field. Unquestionably, progress in TBI research, 
both blast and non-blast, can only benefit from efforts directed specifically to facilitate 
acquisition of human tissue samples linked to detailed clinical information to support robust and 
informative neuropathology studies.  
 
Meanwhile, we must remain cautious in interpreting the significance of any single pathology as 
unique to bTBI based on small and heterogeneous case series and with limited clinical 
information and control comparisons. The alternative is to risk repeating the errors of the past 
decade and the premature assumption that CTE is a unique disease of athletes, or even 
exclusively tau.  
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